Author

Prakash Narayana Reddy

Vignan's Foundation for Science, Technology & ResearchORCID 0000-0002-5771-3218Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Microbiology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Research Focus:drug response / drug discovery· 1 Research Focus:ecology & biodiversity· 1 Assay:metabolomics· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Harish Babu KollaiD· 2 shared SaiArchana Kurucherlapati· 2 shared Rohini Krishna Kota· 1 shared Sai Rupini VemuriiD· 1 shared Vemuri Rupini· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

5 top collaborators · 8 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMicrobiology

Harish Babu KollaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintSep 9, 2026

Co-administration of Staphylococcus aures Fibronectin Binding Protein A N1-3 region and Lipoteichoic acid antigen mixture enhance antibody response in BALB/c mice

Harish Babu Kolla, Rohini Krishna Kota, Vemuri Rupini…·Prakash Narayana Reddy

This study evaluates a multi-antigen vaccine strategy using FnBPA and LTA in BALB/c mice, showing enhanced antibody response and survival against S. aureus.

DOI 10.64898/2026.09.07.745799

mouseproteomics

𝕏 PostBluesky

MicrobiologybioRxivPreprintSep 25, 2025

Active Site Heterogeneity Drives Differential Sialic Acid Metabolism in Enterobacteriaceae Pathogens

Sai Rupini Vemuri, Harish Babu Kolla, SaiArchana Kurucherlapati, Prakash Narayana Reddy

This study investigates how differences in active site structures of the NanA enzyme affect sialic acid metabolism in Enterobacteriaceae pathogens, revealing implications for pathogenicity and therapeutic targets.

DOI 10.1101/2025.09.25.678553

metabolomicsexperimental assay

𝕏 PostBluesky